<?xml version="1.0" encoding="UTF-8"?>
<ref id="B12">
 <label>12.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Beigel</surname>
    <given-names>JH</given-names>
   </name>, 
   <name name-style="western">
    <surname>Nam</surname>
    <given-names>HH</given-names>
   </name>, 
   <name name-style="western">
    <surname>Adams</surname>
    <given-names>PL</given-names>
   </name>, 
   <name name-style="western">
    <surname>Krafft</surname>
    <given-names>A</given-names>
   </name>, 
   <name name-style="western">
    <surname>Ince</surname>
    <given-names>WL</given-names>
   </name>, 
   <name name-style="western">
    <surname>El-Kamary</surname>
    <given-names>SS</given-names>
   </name>, 
   <name name-style="western">
    <surname>Sims</surname>
    <given-names>AC</given-names>
   </name>
  </person-group>
  <year>2019</year>
  <article-title>Advances in respiratory virus therapeutics – a meeting report from the 6th ISIRV Antiviral Group conference</article-title>. 
  <source>Antiviral Res</source>
  <volume>167</volume>:
  <fpage>45</fpage>–
  <lpage>67</lpage>. doi:
  <pub-id pub-id-type="doi">10.1016/j.antiviral.2019.04.006</pub-id>.
  <pub-id pub-id-type="pmid">30974127</pub-id>
 </mixed-citation>
</ref>
